Sanofi to resubmit Lemtrada application for FDA review
April 07, 2014 at 01:16 AM EDT
PARIS, April 7 (Reuters) - Sanofi said it plans to resubmit its application for its Lemtrada drug for the treatment of relapsing forms of multiple sclerosis following "constructive discussions" with the U.S. Food and Drug Administration.
